Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242
Clinical trial NCT02824666 · COMPLETED
Trial details
- NCT number
- NCT02824666
- Sponsor
- Braeburn Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-20
- Primary completion
- 2016-09-06
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.